Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Other financing activities (2023 - 2024)

Rallybio (RLYB) has disclosed Other financing activities for 2 consecutive years, with $11000.0 as the latest value for Q3 2024.

  • Quarterly Other financing activities changed N/A to $11000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $11000.0 through Dec 2025, down 95.9% year-over-year, with the annual reading at $268000.0 for FY2024, 92.81% up from the prior year.
  • Other financing activities hit $11000.0 in Q3 2024 for Rallybio, down from $257000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $257000.0 in Q2 2024 to a low of -$1000.0 in Q2 2023.